Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Technology Tracks Hidden Cancer Cells Faster

By LabMedica International staff writers
Posted on 04 Dec 2025

Targeting and treating disease often hinges on the ability to locate specific cells inside the body—a challenge made difficult because harmful or therapeutic cells move through tissues and are not easily detected. More...

Now, a new technology designed to track these cells with single-cell precision could lead to more effective therapies.

Researchers at Case Western Reserve University (Cleveland, OH, USA) are advancing their technology that enhances the ability to locate therapeutic cells or diseased cells like cancer. Their platform, based on the CryoViz cryo-imaging system, generates high-resolution 3D images using robotics, microscopy, and advanced software. By integrating artificial intelligence (AI) and machine-learning tools, the CryoViz cryo-imaging device can automatically identify healthy and diseased tissues, detect fluorescently labeled cells, and enable “virtual staining” to examine samples at a single-cell level.

By drastically reducing the time and complexity of whole-body imaging—mapping an entire mouse in hours instead of using millions of tissue sections—the approach aims to transform how researchers track metastatic cancer cells, evaluate T-cell behavior during immunotherapy, and assess drug delivery or imaging agents. The team will also use an AI-based “virtual staining” approach to evaluate the body’s tissue at a single-cell level, allowing them to track individual cells such as migrating or metastatic cancer cells and T-cells. This capability will help assess cell-based treatments treatments like immunotherapy.

“The computer can decide when it has detected some “glowing” fluorescent cells, like metastatic tumor cells in the lung,” said CWRU researcher Susann Brady-Kalnay. “It will automatically save tissue sections in that region so I can go back and study the tissue in detail at the cellular and molecular level.”

Related Links
Case Western Reserve University


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.